NCT00660699: A Feasibility Phase II Study in the Treatment of Resected Cholangiocarcinoma, Gallbladder, Pancreatic and Ampullary Cancers |
|
|
| Completed | 2 | 50 | US | Gemcitabine, Gemzar, Docetaxel, Taxotere, Radiation | Washington University School of Medicine | Cholangiocarcinoma Cancer, Gallbladder Cancer, Pancreatic Cancer, Ampullary Cancer | 09/10 | 09/12 | | |
